New Treatment Could Be 'Breakthrough' for Vitiligo

The new therapy includes the oral medication Xeljanz (tofacitinib) -- a drug already approved for use in rheumatoid arthritis patients that dampens the body's immune response -- and ultraviolet-B light therapy.

from WebMD Health http://ift.tt/2nJyXLi